Farzaneh Rahmani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Farzaneh Rahmani has a total of 155 co-authors. Here are the top co-authors by number of shared publications:
- Mohammad Hadi Aarabi
Department of Neuroscience, University of Padova, Padova, Italy
12 shared publications - Nima Rezaei
Research Center for Immunodeficiencies, Pediatrics Center of Excellence, Children's Medical Center Tehran University of Medical Sciences Tehran Iran
5 shared publications Soheila Sobhani
NeuroImaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran; Students' Scientific Research Center, Tehran University of Medical Sciences, Tehran, Iran
5 shared publicationsMahsa Dolatshahi
Student's Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran; NeuroImaging Network (NIN), Universal Scientific Education and Research Network (USERN), Tehran, Iran
4 shared publications- Tammie Lee Smith Benzinger
Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110, USA
4 shared publications - Cyrus A. Raji
Washington University in St Louis
3 shared publications
Latest Publications
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (3)
Large Language Models in Radiology Workflow: Refinement of Differential Diagnosis—An Early Career Perspective
- 1 September 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 320 (3)
Large Language Models in Radiology Workflow: Refinement of Differential Diagnosis—An Early Career Perspective
- Open Access
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e098937
CT‐based Head & Neck Composition Metrics Predict Risk of Conversion to Early Dementia
Background: Visceral adiposity, neck adiposity and sarcopenia are related to Alzheimer disease (AD) risk. Current amyloid confirmatory tests have the highest predictive value where there is high AD pretest probability. CT scan‐derived adipose and fat quantification can provide insights into this probability. We investigated the relationship between head CT composition metrics and risk of AD. Method: We selected participants with normal cognition (Clinical Dementia Rating Scale (CDRÒ=0) and negative amyloid PET at their baseline visit from the Knight Alzheimer Disease Research Center (Knight ADRC) cohort. Based on subsequent CDR measurements, we determined whether each participant: i) stably converted from normal cognition to early dementia (CDR>0) ( dementia converters ) or ii) remained cognitively normal throughout the follow up period ( healthy non‐converters ). The PET/CT scan closest to the last CDR=0 date was then used to extract the low‐dose attenuation correction CT scan necessary to perform CT composition analysis using the Data Analysis Facilitation Suite (DAFS, version 3) platform. Closest brain MRI within 1 year of this PET/CT scan was used for volumetric analyses through FreeSurfer 7.1.1. Survival and correlation analyses were used to test the relationship between head composition metrics and risk of conversion to early dementia and brain volumes, respectively. Result: Total of 500 participants met the inclusion criteria (age: 69±8, 41.8% male, 13.2% African American). Over a median follow up of 123 months, 48(2.6%) stably converted to early dementia. Individuals with higher fraction of inter‐intramuscular adipose tissue in the head have a 3‐times increased risk of conversion from normal cognition to early dementia (Figure A). Males, but not females, with higher normalized temporalis muscle volume were protected against conversion to early dementia (HR(95%CI):0.3(0.1‐0.8)), suggesting sex differences in this relationship (Figure B). Correlation analyses showed a direct relationship between the volume of the temporalis muscles and volume of the precuneus and entorhinal cortices that persisted even after correction for total intracranial volume (Figure C and D). Conclusion: Head and neck composition metrics inform future risk of dementia and correlate with brain atrophy suggesting a potential role for automated CT‐based screening paradigms based on this method.
- 24 December 2025
- Published by Wiley in Alzheimer's & Dementia
- Vol. 21 (S2) , e098937
Open AccessCT‐based Head & Neck Composition Metrics Predict Risk of Conversion to Early Dementia
Background: Visceral adiposity, neck adiposity and sarcopenia are related to Alzheimer disease (AD) risk. Current amyloid confirmatory tests have the highest predictive value where there is high AD pretest probability. CT scan‐derived adipose and fat quantification can provide insights into this probability. We investigated the relationship between head CT composition metrics and risk of AD. Method: We selected participants with normal cognition (Clinical Dementia Rating Scale (CDRÒ=0) and negative amyloid PET at their baseline visit from the Knight Alzheimer Disease Research Center (Knight ADRC) cohort. Based on subsequent CDR measurements, we determined whether each participant: i) stably converted from normal cognition to early dementia (CDR>0) ( dementia converters ) or ii) remained cognitively normal throughout the follow up period ( healthy non‐converters ). The PET/CT scan closest to the last CDR=0 date was then used to extract the low‐dose attenuation correction CT scan necessary to perform CT composition analysis using the Data Analysis Facilitation Suite (DAFS, version 3) platform. Closest brain MRI within 1 year of this PET/CT scan was used for volumetric analyses through FreeSurfer 7.1.1. Survival and correlation analyses were used to test the relationship between head composition metrics and risk of conversion to early dementia and brain volumes, respectively. Result: Total of 500 participants met the inclusion criteria (age: 69±8, 41.8% male, 13.2% African American). Over a median follow up of 123 months, 48(2.6%) stably converted to early dementia. Individuals with higher fraction of inter‐intramuscular adipose tissue in the head have a 3‐times increased risk of conversion from normal cognition to early dementia (Figure A). Males, but not females, with higher normalized temporalis muscle volume were protected against conversion to early dementia (HR(95%CI):0.3(0.1‐0.8)), suggesting sex differences in this relationship (Figure B). Correlation analyses showed a direct relationship between the volume of the temporalis muscles and volume of the precuneus and entorhinal cortices that persisted even after correction for total intracranial volume (Figure C and D). Conclusion: Head and neck composition metrics inform future risk of dementia and correlate with brain atrophy suggesting a potential role for automated CT‐based screening paradigms based on this method.
- 28 July 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (1) , 175-183
Evaluation of [ 11 C]CS1P1 in Healthy Young and Older Adults
BACKGROUND AND PURPOSE: Sphingosine-1-phosphate receptor 1 (S1PR1) is a key regulator of neuroinflammation and plays a crucial role in multiple neurodegenerative diseases. [11C]CS1P1 is a novel PET tracer for measuring expression levels of S1PR1 in humans. Before widespread application, its quantification must be established and evaluated in healthy young and old adults through characterization of binding topographies, kinetics, and tracer metabolism rates. MATERIALS AND METHODS: We acquired dynamic [11C]CS1P1 emission data from 29 healthy controls and investigated the topography of [11C]CS1P1 uptake, radiolabeled metabolites of the tracer, an image-derived input function estimation, and tissue compartment modeling. RESULTS: The image derived input function approximated the arterially sampled input function. Further, radiolabeled metabolites of the tracer accumulated linearly throughout the scan and demonstrated consistency across participants. A two-tissue compartment model fitted the observed emission data well, consistent with previously reported nonhuman primate studies. Kinetic modeling using the image derived input functions, corrected by population estimates of tracer metabolism, provided a good fit for tissue activity curves. Graphical Logan analysis reliably estimated volume of distribution (Vt), and Vt closely reproduced S1PR1 distribution in the brain. CONCLUSIONS: In this study, we have established a quantitative [11C]CS1P1 PET processing approach using a two-tissue compartment model and imaging-derived input function with population metabolite correction. [11C]CS1P1 PET reflects S1PR1 topography and supports its use for investigating neuroinflammation in humans. ABBREVIATIONS: S1PR1= Sphingosine-1-phosphate receptor 1; Vt=volume of distribution; IDIF= Image-Derived Input Function.
- 28 July 2025
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 47 (1) , 175-183
Evaluation of [ 11 C]CS1P1 in Healthy Young and Older Adults
BACKGROUND AND PURPOSE: Sphingosine-1-phosphate receptor 1 (S1PR1) is a key regulator of neuroinflammation and plays a crucial role in multiple neurodegenerative diseases. [11C]CS1P1 is a novel PET tracer for measuring expression levels of S1PR1 in humans. Before widespread application, its quantification must be established and evaluated in healthy young and old adults through characterization of binding topographies, kinetics, and tracer metabolism rates. MATERIALS AND METHODS: We acquired dynamic [11C]CS1P1 emission data from 29 healthy controls and investigated the topography of [11C]CS1P1 uptake, radiolabeled metabolites of the tracer, an image-derived input function estimation, and tissue compartment modeling. RESULTS: The image derived input function approximated the arterially sampled input function. Further, radiolabeled metabolites of the tracer accumulated linearly throughout the scan and demonstrated consistency across participants. A two-tissue compartment model fitted the observed emission data well, consistent with previously reported nonhuman primate studies. Kinetic modeling using the image derived input functions, corrected by population estimates of tracer metabolism, provided a good fit for tissue activity curves. Graphical Logan analysis reliably estimated volume of distribution (Vt), and Vt closely reproduced S1PR1 distribution in the brain. CONCLUSIONS: In this study, we have established a quantitative [11C]CS1P1 PET processing approach using a two-tissue compartment model and imaging-derived input function with population metabolite correction. [11C]CS1P1 PET reflects S1PR1 topography and supports its use for investigating neuroinflammation in humans. ABBREVIATIONS: S1PR1= Sphingosine-1-phosphate receptor 1; Vt=volume of distribution; IDIF= Image-Derived Input Function.
- Open Access
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Body Mass Index, but not Visceral Abdominal Obesity and Insulin Resistance, Negatively Impacts White Matter Microstructure in Midlife
Background: Midlife obesity, as evidenced by high body mass index (BMI), is increasingly understood as a risk factor for development of Alzheimer’s disease. Importantly, visceral fat, by producing adipokines, contributes to inflammation as well as insulin resistance, mechanisms involved in development of Alzheimer’s disease. Herein, we aimed to assess association of white matter microstructure, measured by Diffusion tensor imaging (DTI), with obesity and abdominal adipose tissue composition at midlife.Method: A total of 34 middle‐aged (age: 51.27 ± 6.12 years, BMI: 32.28 ± 6.39 kg/m2), cognitively normal participants, underwent bloodwork, brain and abdominal MRI. Insulin resistance status was assessed using Homeostatic Model Assessment for Insulin Resistance. Abdominal visceral and subcutaneous adipose tissue (VAT, SAT) were automatically segmented using VOXel Analysis Suite (Voxa) and VAT/SAT ratio was calculated. A diffusion spectrum imaging scheme with a total of 98 diffusion samplings and a voxel size of 2 mm was acquired. Using DSI studio (https://dsi‐studio.labsolver.org/), the diffusion data were reconstructed using generalized q‐sampling imaging and the tensor metrics were calculated. Fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD, respectively) for white matter tracts were compared across study groups using one‐way ANOVA. Multiple regression models with sex, age, and education as covariates were used to assess the association of BMI, VAT/SAT ratio, and HOMA‐IR with DTI metrics.Result: Our data showed that BMI was negatively associated with AD values in right inferior fronto‐occipital fasciculus, tapetum and forceps major of Corpus Callosum (CC), superior and middle cerebellar peduncle, and bilateral reticular tract. The negative association of BMI with AD values in tapetum of CC was significant only in women. Right reticular tract MD and superior cerebellar peduncle MD and RD values were also significantly associated with BMI. There were no significant associations between neither of diffusion metrics and VAT/SAT ratio or HOMA‐IR.Conclusion: Association of midlife obesity with lower axonal diffusivity, reflective of lower white matter integrity, with differential patterns in men and women especially in CC, is in line with previous findings in healthy individuals. Reduced axonal diffusivity in reticular and brain stem pathways could be indicative of early dysregulations observed in Alzheimer’s disease.
- 25 December 2023
- Published by Wiley in Alzheimer's & Dementia
- Vol. 19 (S17)
Open AccessBody Mass Index, but not Visceral Abdominal Obesity and Insulin Resistance, Negatively Impacts White Matter Microstructure in Midlife
Background: Midlife obesity, as evidenced by high body mass index (BMI), is increasingly understood as a risk factor for development of Alzheimer’s disease. Importantly, visceral fat, by producing adipokines, contributes to inflammation as well as insulin resistance, mechanisms involved in development of Alzheimer’s disease. Herein, we aimed to assess association of white matter microstructure, measured by Diffusion tensor imaging (DTI), with obesity and abdominal adipose tissue composition at midlife.Method: A total of 34 middle‐aged (age: 51.27 ± 6.12 years, BMI: 32.28 ± 6.39 kg/m2), cognitively normal participants, underwent bloodwork, brain and abdominal MRI. Insulin resistance status was assessed using Homeostatic Model Assessment for Insulin Resistance. Abdominal visceral and subcutaneous adipose tissue (VAT, SAT) were automatically segmented using VOXel Analysis Suite (Voxa) and VAT/SAT ratio was calculated. A diffusion spectrum imaging scheme with a total of 98 diffusion samplings and a voxel size of 2 mm was acquired. Using DSI studio (https://dsi‐studio.labsolver.org/), the diffusion data were reconstructed using generalized q‐sampling imaging and the tensor metrics were calculated. Fractional anisotropy (FA), mean, axial, and radial diffusivity (MD, AD, RD, respectively) for white matter tracts were compared across study groups using one‐way ANOVA. Multiple regression models with sex, age, and education as covariates were used to assess the association of BMI, VAT/SAT ratio, and HOMA‐IR with DTI metrics.Result: Our data showed that BMI was negatively associated with AD values in right inferior fronto‐occipital fasciculus, tapetum and forceps major of Corpus Callosum (CC), superior and middle cerebellar peduncle, and bilateral reticular tract. The negative association of BMI with AD values in tapetum of CC was significant only in women. Right reticular tract MD and superior cerebellar peduncle MD and RD values were also significantly associated with BMI. There were no significant associations between neither of diffusion metrics and VAT/SAT ratio or HOMA‐IR.Conclusion: Association of midlife obesity with lower axonal diffusivity, reflective of lower white matter integrity, with differential patterns in men and women especially in CC, is in line with previous findings in healthy individuals. Reduced axonal diffusivity in reticular and brain stem pathways could be indicative of early dysregulations observed in Alzheimer’s disease.
- Open Access
- 23 October 2023
- Published by Wiley in Human Brain Mapping
- Vol. 44 (18) , 6375-6387
T1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease
Carriers of mutations responsible for dominantly inherited Alzheimer disease provide a unique opportunity to study potential imaging biomarkers. Biomarkers based on routinely acquired clinical MR images, could supplement the extant invasive or logistically challenging) biomarker studies. We used 1104 longitudinal MR, 324 amyloid beta, and 87 tau positron emission tomography imaging sessions from 525 participants enrolled in the Dominantly Inherited Alzheimer Network Observational Study to extract novel imaging metrics representing the mean (μ) and standard deviation (σ) of standardized image intensities of T1‐weighted and Fluid attenuated inversion recovery (FLAIR) MR scans. There was an exponential decrease in FLAIR‐μ in mutation carriers and an increase in FLAIR and T1 signal heterogeneity (T1‐σ and FLAIR‐σ) as participants approached the symptom onset in both supramarginal, the right postcentral and right superior temporal gyri as well as both caudate nuclei, putamina, thalami, and amygdalae. After controlling for the effect of regional atrophy, FLAIR‐μ decreased and T1‐σ and FLAIR‐σ increased with increasing amyloid beta and tau deposition in numerous cortical regions. In symptomatic mutation carriers and independent of the effect of regional atrophy, tau pathology demonstrated a stronger relationship with image intensity metrics, compared with amyloid pathology. We propose novel MR imaging intensity‐based metrics using standard clinical T1 and FLAIR images which strongly associates with the progression of pathology in dominantly inherited Alzheimer disease. We suggest that tau pathology may be a key driver of the observed changes in this cohort of patients.
- 23 October 2023
- Published by Wiley in Human Brain Mapping
- Vol. 44 (18) , 6375-6387
Open AccessT1 and FLAIR signal intensities are related to tau pathology in dominantly inherited Alzheimer disease
Carriers of mutations responsible for dominantly inherited Alzheimer disease provide a unique opportunity to study potential imaging biomarkers. Biomarkers based on routinely acquired clinical MR images, could supplement the extant invasive or logistically challenging) biomarker studies. We used 1104 longitudinal MR, 324 amyloid beta, and 87 tau positron emission tomography imaging sessions from 525 participants enrolled in the Dominantly Inherited Alzheimer Network Observational Study to extract novel imaging metrics representing the mean (μ) and standard deviation (σ) of standardized image intensities of T1‐weighted and Fluid attenuated inversion recovery (FLAIR) MR scans. There was an exponential decrease in FLAIR‐μ in mutation carriers and an increase in FLAIR and T1 signal heterogeneity (T1‐σ and FLAIR‐σ) as participants approached the symptom onset in both supramarginal, the right postcentral and right superior temporal gyri as well as both caudate nuclei, putamina, thalami, and amygdalae. After controlling for the effect of regional atrophy, FLAIR‐μ decreased and T1‐σ and FLAIR‐σ increased with increasing amyloid beta and tau deposition in numerous cortical regions. In symptomatic mutation carriers and independent of the effect of regional atrophy, tau pathology demonstrated a stronger relationship with image intensity metrics, compared with amyloid pathology. We propose novel MR imaging intensity‐based metrics using standard clinical T1 and FLAIR images which strongly associates with the progression of pathology in dominantly inherited Alzheimer disease. We suggest that tau pathology may be a key driver of the observed changes in this cohort of patients.
- Open Access
- 30 August 2023
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 32 (2) , 15-26
Functional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate
Functional 1H magnetic resonance spectroscopy (fMRS) is a derivative of dynamic MRS imaging. This modality links physiologic metabolic responses with available activity and measures absolute or relative concentrations of various metabolites. According to clinical evidence, the mitochondrial glycolysis pathway is disrupted in many nervous system disorders, especially Alzheimer disease, resulting in the activation of anaerobic glycolysis and an increased rate of lactate production. Our study evaluates fMRS with J-editing as a cutting-edge technique to detect lactate in Alzheimer disease. In this modality, functional activation is highlighted by signal subtractions of lipids and macromolecules, which yields a much higher signal-to-noise ratio and enables better detection of trace levels of lactate compared with other modalities. However, until now, clinical evidence is not conclusive regarding the widespread use of this diagnostic method. The complex machinery of cellular and noncellular modulators in lactate metabolism has obscured the potential roles fMRS imaging can have in dementia diagnosis. Recent developments in MRI imaging such as the advent of 7 Tesla machines and new image reconstruction methods, coupled with a renewed interest in the molecular and cellular basis of Alzheimer disease, have reinvigorated the drive to establish new clinical options for the early detection of Alzheimer disease. Based on the latter, lactate has the potential to be investigated as a novel diagnostic and prognostic marker for Alzheimer disease.
- 30 August 2023
- Published by Wolters Kluwer Health in Topics in Magnetic Resonance Imaging
- Vol. 32 (2) , 15-26
Open AccessFunctional Magnetic Resonance Spectroscopy of Lactate in Alzheimer Disease: A Comprehensive Review of Alzheimer Disease Pathology and the Role of Lactate
Functional 1H magnetic resonance spectroscopy (fMRS) is a derivative of dynamic MRS imaging. This modality links physiologic metabolic responses with available activity and measures absolute or relative concentrations of various metabolites. According to clinical evidence, the mitochondrial glycolysis pathway is disrupted in many nervous system disorders, especially Alzheimer disease, resulting in the activation of anaerobic glycolysis and an increased rate of lactate production. Our study evaluates fMRS with J-editing as a cutting-edge technique to detect lactate in Alzheimer disease. In this modality, functional activation is highlighted by signal subtractions of lipids and macromolecules, which yields a much higher signal-to-noise ratio and enables better detection of trace levels of lactate compared with other modalities. However, until now, clinical evidence is not conclusive regarding the widespread use of this diagnostic method. The complex machinery of cellular and noncellular modulators in lactate metabolism has obscured the potential roles fMRS imaging can have in dementia diagnosis. Recent developments in MRI imaging such as the advent of 7 Tesla machines and new image reconstruction methods, coupled with a renewed interest in the molecular and cellular basis of Alzheimer disease, have reinvigorated the drive to establish new clinical options for the early detection of Alzheimer disease. Based on the latter, lactate has the potential to be investigated as a novel diagnostic and prognostic marker for Alzheimer disease.
- Open Access
- 16 February 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (3) , 261-267
Validity Assessment of an Automated Brain Morphometry Tool for Patients with De Novo Memory Symptoms
BACKGROUND AND PURPOSE: Automated volumetric analysis of structural MR imaging allows quantitative assessment of brain atrophy in neurodegenerative disorders. We compared the brain segmentation performance of the AI-Rad Companion brain MR imaging software against an in-house FreeSurfer 7.1.1/Individual Longitudinal Participant pipeline. MATERIALS AND METHODS: T1-weighted images of 45 participants with de novo memory symptoms were selected from the OASIS-4 database and analyzed through the AI-Rad Companion brain MR imaging tool and the FreeSurfer 7.1.1/Individual Longitudinal Participant pipeline. Correlation, agreement, and consistency between the 2 tools were compared among the absolute, normalized, and standardized volumes. Final reports generated by each tool were used to compare the rates of detection of abnormality and the compatibility of radiologic impressions made using each tool, compared with the clinical diagnoses. RESULTS: We observed strong correlation, moderate consistency, and poor agreement between absolute volumes of the main cortical lobes and subcortical structures measured by the AI-Rad Companion brain MR imaging tool compared with FreeSurfer. The strength of the correlations increased after normalizing the measurements to the total intracranial volume. Standardized measurements differed significantly between the 2 tools, likely owing to differences in the normative data sets used to calibrate each tool. When considering the FreeSurfer 7.1.1/Individual Longitudinal Participant pipeline as a reference standard, the AI-Rad Companion brain MR imaging tool had a specificity of 90.6%–100% and a sensitivity of 64.3%–100% in detecting volumetric abnormalities. There was no difference between the rate of compatibility of radiologic and clinical impressions when using the 2 tools. CONCLUSIONS: The AI-Rad Companion brain MR imaging tool reliably detects atrophy in cortical and subcortical regions implicated in the differential diagnosis of dementia.
- 16 February 2023
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 44 (3) , 261-267
Open AccessValidity Assessment of an Automated Brain Morphometry Tool for Patients with De Novo Memory Symptoms
BACKGROUND AND PURPOSE: Automated volumetric analysis of structural MR imaging allows quantitative assessment of brain atrophy in neurodegenerative disorders. We compared the brain segmentation performance of the AI-Rad Companion brain MR imaging software against an in-house FreeSurfer 7.1.1/Individual Longitudinal Participant pipeline. MATERIALS AND METHODS: T1-weighted images of 45 participants with de novo memory symptoms were selected from the OASIS-4 database and analyzed through the AI-Rad Companion brain MR imaging tool and the FreeSurfer 7.1.1/Individual Longitudinal Participant pipeline. Correlation, agreement, and consistency between the 2 tools were compared among the absolute, normalized, and standardized volumes. Final reports generated by each tool were used to compare the rates of detection of abnormality and the compatibility of radiologic impressions made using each tool, compared with the clinical diagnoses. RESULTS: We observed strong correlation, moderate consistency, and poor agreement between absolute volumes of the main cortical lobes and subcortical structures measured by the AI-Rad Companion brain MR imaging tool compared with FreeSurfer. The strength of the correlations increased after normalizing the measurements to the total intracranial volume. Standardized measurements differed significantly between the 2 tools, likely owing to differences in the normative data sets used to calibrate each tool. When considering the FreeSurfer 7.1.1/Individual Longitudinal Participant pipeline as a reference standard, the AI-Rad Companion brain MR imaging tool had a specificity of 90.6%–100% and a sensitivity of 64.3%–100% in detecting volumetric abnormalities. There was no difference between the rate of compatibility of radiologic and clinical impressions when using the 2 tools. CONCLUSIONS: The AI-Rad Companion brain MR imaging tool reliably detects atrophy in cortical and subcortical regions implicated in the differential diagnosis of dementia.
- 13 March 2021
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 71 (7) , 1410-1424
Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases
Accumulation of misfolded tau, amyloid β (Aβ), and alpha-synuclein (α-syn) proteins is the fundamental contributor to many neurodegenerative diseases, namely Parkinson’s (PD) and AD. Such protein aggregations trigger activation of immune mechanisms in neuronal and glial, mainly M1-type microglia cells, leading to release of pro-inflammatory mediators, and subsequent neuronal dysfunction and apoptosis. Despite the described neurotoxic features for glial cells, recruitment of peripheral leukocytes to the brain and their conversion to neuroprotective M2-type microglia can mitigate neurodegeneration by clearing extracellular protein accumulations or residues. Based on these observations, it was speculated that Dendritic cell (DC)-based vaccination, by making use of DCs as natural adjuvants, could be used for treatment of neurodegenerative disorders. DCs potentiated by disease-specific antigens can also enhance T helper 2 (Th2)-specific immune response and by production of specific antibodies contribute to clearance of intracellular aggregations, as well as enhancing regulatory T cell response. Thus, enhancement of immune response by DC vaccine therapy can potentially augment glial polarization into the neuroprotective phenotype, enhance antibody production, and at the same time balance neuronal cells’ repair, renewal, and protection. The characteristic feature of this method of treatment is to maintain the equilibrium in the immune response rather than targeting a single mediator in the disease and their application in other neurodegenerative diseases should be addressed. However, the safety of these methods should be investigated by clinical trials.
- 13 March 2021
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 71 (7) , 1410-1424
Modification of Glial Cell Activation through Dendritic Cell Vaccination: Promises for Treatment of Neurodegenerative Diseases
Accumulation of misfolded tau, amyloid β (Aβ), and alpha-synuclein (α-syn) proteins is the fundamental contributor to many neurodegenerative diseases, namely Parkinson’s (PD) and AD. Such protein aggregations trigger activation of immune mechanisms in neuronal and glial, mainly M1-type microglia cells, leading to release of pro-inflammatory mediators, and subsequent neuronal dysfunction and apoptosis. Despite the described neurotoxic features for glial cells, recruitment of peripheral leukocytes to the brain and their conversion to neuroprotective M2-type microglia can mitigate neurodegeneration by clearing extracellular protein accumulations or residues. Based on these observations, it was speculated that Dendritic cell (DC)-based vaccination, by making use of DCs as natural adjuvants, could be used for treatment of neurodegenerative disorders. DCs potentiated by disease-specific antigens can also enhance T helper 2 (Th2)-specific immune response and by production of specific antibodies contribute to clearance of intracellular aggregations, as well as enhancing regulatory T cell response. Thus, enhancement of immune response by DC vaccine therapy can potentially augment glial polarization into the neuroprotective phenotype, enhance antibody production, and at the same time balance neuronal cells’ repair, renewal, and protection. The characteristic feature of this method of treatment is to maintain the equilibrium in the immune response rather than targeting a single mediator in the disease and their application in other neurodegenerative diseases should be addressed. However, the safety of these methods should be investigated by clinical trials.
- Open Access
- 15 October 2020
- Published by Wiley in Brain and Behavior
- Vol. 10 (12) , e01895
Intact microstructure of the right corticostriatal pathway predicts creative ability in healthy adults
Introduction: Creativity is one of the most complex functions of the human brain. The corticostriatal pathways have been implicated in creative thinking, yet few studies have addressed the microstructural underpinnings of creative ability, especially those related to the corticostriatal dopaminergic circuitry. We hypothesized that performance in creativity tests can be predicted based on diffusion metrics of the corticostriatal pathways and basal ganglia.Methods: A total of 37 healthy adults were included. Neuropsychological tests of creativity, including the alternative uses task (AUT), test of creative imagery abilities (TCIA), remote associates test (RAT), and creative achievement questionnaire (CAQ), as well as diffusion MRI data were acquired for each participant.Results: We demonstrated an independent effect of TCIA originality and TCIA transformativeness subscores, and RAT score in predicting the mean diffusivity (MD), mean axial diffusivity (AD), mean fractional anisotropy (FA), and mean generalized FA of the right corticostriatal pathway. We also observed independent effects of AUT elaboration subscore in predicting the AD of the right substantia nigra, and radial diffusivity (RD) of the right globus pallidus.Conclusion: Our results put a further spin on the “creative right brain” notion and question the presence of high‐creative and low‐creative networks in the brain.
- 15 October 2020
- Published by Wiley in Brain and Behavior
- Vol. 10 (12) , e01895
Open AccessIntact microstructure of the right corticostriatal pathway predicts creative ability in healthy adults
Introduction: Creativity is one of the most complex functions of the human brain. The corticostriatal pathways have been implicated in creative thinking, yet few studies have addressed the microstructural underpinnings of creative ability, especially those related to the corticostriatal dopaminergic circuitry. We hypothesized that performance in creativity tests can be predicted based on diffusion metrics of the corticostriatal pathways and basal ganglia.Methods: A total of 37 healthy adults were included. Neuropsychological tests of creativity, including the alternative uses task (AUT), test of creative imagery abilities (TCIA), remote associates test (RAT), and creative achievement questionnaire (CAQ), as well as diffusion MRI data were acquired for each participant.Results: We demonstrated an independent effect of TCIA originality and TCIA transformativeness subscores, and RAT score in predicting the mean diffusivity (MD), mean axial diffusivity (AD), mean fractional anisotropy (FA), and mean generalized FA of the right corticostriatal pathway. We also observed independent effects of AUT elaboration subscore in predicting the AD of the right substantia nigra, and radial diffusivity (RD) of the right globus pallidus.Conclusion: Our results put a further spin on the “creative right brain” notion and question the presence of high‐creative and low‐creative networks in the brain.
- 6 August 2020
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 41 (8) , 1487-1494
Indentation and Transverse Diameter of the Meckel Cave: Imaging Markers to Diagnose Idiopathic Intracranial Hypertension
BACKGROUND AND PURPOSE: Clinical and imaging manifestations of idiopathic intracranial hypertension should prompt early diagnosis and treatment to avoid complications. Multiple diagnostic imaging criteria are reported to suggest the diagnosis of idiopathic intracranial hypertension with questionable sensitivity and/or specificity. Increased intracranial pressure results in dilation of the perineural cisternal spaces such as the optic nerve sheaths and the Meckel cave. It may also cause protrusion of cisternal structures of the Meckel cave through the skull base foramina, which could result in indentation or a bilobed appearance of the Meckel cave. We investigated the changes in the Meckel cave in patients with proved idiopathic intracranial hypertension versus healthy controls. MATERIALS AND METHODS: We studied 75 patients with a diagnosis of idiopathic intracranial hypertension and 75 age-and sex-matched healthy controls. The transverse diameter of Meckel cave was measured in the axial and coronal planes of T2-weighted MR imaging sequences, and comparison was made between the 2 groups. RESULTS: The mean diameters of the Meckel cave on the coronal T2 plane in patients with idiopathic intracranial hypertension were 5.21 ± 1.22 mm on the right side and 5.16 ± 0.90 mm on the left side, while in the control group, they measured 3.89 ± 0.62 mm and 4.09 ± 0.68 mm, respectively (P value < .001). Of 75 patients with an approved diagnosis of idiopathic intracranial hypertension, 57 (76%) showed an indented Meckel cave as opposed to 21 (28%) in the control group. CONCLUSIONS: Our results confirm for the first time that the shape and size of the Meckel cave can be used as sensitive and specific diagnostic imaging markers for the diagnosis of idiopathic intracranial hypertension.
- 6 August 2020
- Published by American Society of Neuroradiology (ASNR) in American Journal of Neuroradiology
- Vol. 41 (8) , 1487-1494
Indentation and Transverse Diameter of the Meckel Cave: Imaging Markers to Diagnose Idiopathic Intracranial Hypertension
BACKGROUND AND PURPOSE: Clinical and imaging manifestations of idiopathic intracranial hypertension should prompt early diagnosis and treatment to avoid complications. Multiple diagnostic imaging criteria are reported to suggest the diagnosis of idiopathic intracranial hypertension with questionable sensitivity and/or specificity. Increased intracranial pressure results in dilation of the perineural cisternal spaces such as the optic nerve sheaths and the Meckel cave. It may also cause protrusion of cisternal structures of the Meckel cave through the skull base foramina, which could result in indentation or a bilobed appearance of the Meckel cave. We investigated the changes in the Meckel cave in patients with proved idiopathic intracranial hypertension versus healthy controls. MATERIALS AND METHODS: We studied 75 patients with a diagnosis of idiopathic intracranial hypertension and 75 age-and sex-matched healthy controls. The transverse diameter of Meckel cave was measured in the axial and coronal planes of T2-weighted MR imaging sequences, and comparison was made between the 2 groups. RESULTS: The mean diameters of the Meckel cave on the coronal T2 plane in patients with idiopathic intracranial hypertension were 5.21 ± 1.22 mm on the right side and 5.16 ± 0.90 mm on the left side, while in the control group, they measured 3.89 ± 0.62 mm and 4.09 ± 0.68 mm, respectively (P value < .001). Of 75 patients with an approved diagnosis of idiopathic intracranial hypertension, 57 (76%) showed an indented Meckel cave as opposed to 21 (28%) in the control group. CONCLUSIONS: Our results confirm for the first time that the shape and size of the Meckel cave can be used as sensitive and specific diagnostic imaging markers for the diagnosis of idiopathic intracranial hypertension.